FDA Roundup: March 22, 2024 – Legal Tech Monitor

This post was originally published on this site

SILVER SPRING, Md., March 22, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention)…

Related Posts

ASDSA Alerts Nation’s Governors to New Trend in Anti-transgender…

Bernstein Litowitz Berger &amp; Grossmann LLP Announces Notice of Pendency and Proposed Settlement of Stockholder Class and Derivative Action Involving Holders of Sirius XM Holdings Inc. Common Stock as of the Close of Trading on January 5, 2024

Election Results for 2024 NCC Board of Directors and Officers

Bernstein Litowitz Berger & Grossmann LLP Announces Notice of Pendency and Proposed Settlement of Stockholder Class and Derivative Action Involving Holders of Sirius XM Holdings Inc. Common Stock as of the Close of Trading on January 5, 2024